Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes
Reps will be promoting Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes.
Think of it as similar to Januvia.
Onglyza (saxagliptin) and Januvia (sitagliptin) are incretin enhancers. They prolong the action of endogenous incretin hormones by blocking their breakdown by the enzyme, dipeptidyl peptidase-4 (DPP-4). This leads to more insulin release after eating.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote